Skip to main content
Premium Trial:

Request an Annual Quote

Maria Fe Paz

Rosetta Genomics has appointed Maria Fe Paz as interim chief medical officer with plans to transition her to chief medical officer upon receipt of a valid work visa that supports her planned relocation to the US. Paz joins Rosetta Genomics from Labceutics were she was the founder-president and the Diaceutics Group where she served as chief medical officer. Prior to joining Diaceutics and founding Labceutics, she served as head of translational medicine and scientific development at Zeltia. Paz's earlier experience includes founding and serving as the scientific-medical consultant for Epicure Molecular, serving as head of the epigenetics unit at the Spanish National Cardiovascular Center, and she was founder and director of molecular and genetic diagnostics laboratories in Hospital de Madrid. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.